Preexisting mild sleep disturbance as a vulnerability factor for inflammation-induced depressed mood: A human experimental study

Translational Psychiatry

Volumn 6, Issue 3, 2016, Pages

  Cho, H J ^a   Eisenberger, N I ^b   Olmstead, R ^a   Breen, E C ^a   Irwin, M R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RESPONSE; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; PITTSBURGH SLEEP QUALITY INDEX; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SLEEP DISORDER; SLEEP QUALITY; YOUNG ADULT; ADOLESCENT; COMPLICATION; MIDDLE AGED; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX RATIO;

ADOLESCENT; ADULT; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SLEEP WAKE DISORDERS; YOUNG ADULT;

EID: 84982754599     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2016.23     Document Type: Article

References (42)

1. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011; 9: 90.
2. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851–858.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
4. Depression Guideline Panel. Depression in Primary Care, vol 2: Treatment of Major Depression. Clinical Practice Guideline 5. US Department of Health and Human Services, PHS, Agency for Health Care Policy and Research: Rockville, MD, USA, 1993.
5. Raedler TJ. Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry 2011; 24: 519–525.
6. LeBlanc M, Merette C, Savard J, Ivers H, Baillargeon L, Morin CM. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009; 32: 1027–1037.
7. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006; 7: 123–130.
8. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6: 97–111.
9. Ohayon M. Epidemiological study on insomnia in the general population. Sleep 1996; 19(3 Suppl): S7–15.
10. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 2011; 135: 10–19.
11. Irwin MR. Why sleep is important for health: a psychoneuroimmunology per-spective. Annu Rev Psychol 2015; 66: 143–172.
12. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO et al. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001; 107: 165–170.
13. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endo-crinol Metab 1999; 84: 2603–2607.
14. Redwine L, Dang J, Hall M, Irwin M. Disordered sleep, nocturnal cytokines, and immunity in alcoholics. Psychosom Med 2003; 65: 75–85.
15. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflam-mation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry 2016; e-pub ahead of print.
16. Irwin MR, Wang M, Ribeiro D, Cho HJ, Olmstead R, Breen EC et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry 2008; 64: 538–540.
17. Irwin MR, Carrillo C, Olmstead R. Sleep loss activates cellular markers of inflam-mation: sex differences. Brain Behav Immun 2010; 24: 54–57.
18. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006; 166: 1756–1762.
19. Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav Immun 2010; 24: 558–563.
20. Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 2009; 47: 881–890.
21. Moieni M, Irwin MR, Jevtic I, Olmstead R, Breen EC, Eisenberger NI. Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology 2015; 40: 1709–1716.
22. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777–780.
23. Cappuccio FP, Stranges S, Kandala NB, Miller MA, Taggart FM, Kumari M et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension 2007; 50: 693–700.
24. Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 2000; 48: 115–123.
25. Kuehner C. Gender differences in unipolar depression: an update of epidemio-logical findings and possible explanations. Acta Psychiatr Scand 2003; 108: 163–174.
26. DellaGioia N, Hannestad J. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev 2010; 34: 130–143.
27. Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144: 480–484.
28. Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun 2007; 21: 901–912.
29. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory pro-liferative disease. Cytokine Growth Factor Rev 2002; 13: 357–368.
30. Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebmann P, Kaulfersch W et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995; 38: 211–220.
31. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193–213.
32. McNair DM, Lorr M, Droppleman LF. Manual for the Profile of Mood States. Education and Industrial Testing Service: San Diego, CA, USA, 1971.
33. Baker F, Denniston M, Zabora J, Polland A, Dudley WN. A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology 2002; 11: 273–281.
34. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–571.
35. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004; 61: 310–317.
36. First MB, Gibbon M. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders: SCID-1 Clinician Version. American Psychiatric Pub: Washington, DC, USA, 1997.
37. Cole JC, Motivala SJ, Buysse DJ, Oxman MN, Levin MJ, Irwin MR. Validation of a 3-factor scoring model for the Pittsburgh sleep quality index in older adults. Sleep 2006; 29: 112–116.
38. Schedlowski M, Engler H, Grigoleit JS. Endotoxin-induced experimental systemic inflammation in humans: a model to disentangle immune-to-brain communica-tion. Brain Behav Immun 2014; 35: 1–8.
39. Franzen PL, Buysse DJ, Rabinovitz M, Pollock BG, Lotrich FE. Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment. Psychiatry Res 2010; 177: 240–245.
40. Zielinski MR, Krueger JM. Sleep and innate immunity. Front Biosci (Schol Ed) 2011; 3: 632–642.
41. Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald JD, Ranganath VK et al. Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 2012; 35: 537–543.
42. Miller GE, Cole SW. Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol Psychiatry 72: 34–40.